Cite

HARVARD Citation

    Ye, N. et al. (2021). Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease. Circulation. 143 (18), pp. 1735-1749. [Online]. 
  
Back to record